tag:blogger.com,1999:blog-35831423.post6005138694233311948..comments2023-10-10T12:06:45.021-04:00Comments on Xcovery blog - kinase industry knowledge collected and sometimes analyzed: A couple of extra thoughts from 2006Anonymoushttp://www.blogger.com/profile/10111261251379767528noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-35831423.post-60126565487256104422007-02-24T16:01:00.000-05:002007-02-24T16:01:00.000-05:00If you consider the initial sales projections for ...If you consider the initial sales projections for Glivec (?? ~250m USD pa??) and actual sales (?? >2bn USD pa) perhaps the success of Iressa isn't all that surprising.<BR/><BR/>Maybe oncologists out there are giving it a shot off-label in poor prognosis cases, in combination with other medications? I am not at all clued up on the side-effect profile, but if it's not too bad, the oncologists may be thinking, Can it do any harm to give it a shot?Anonymousnoreply@blogger.com